All Information (Except Text) for S.2514 - PACED Act115th Congress (2017-2018)
|Sponsor:||Sen. Cotton, Tom [R-AR] (Introduced 03/07/2018)|
|Committees:||Senate - Judiciary|
|Latest Action:||Senate - 03/07/2018 Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Short Titles - Senate
Short Titles as Introduced
Preserving Access to Cost Effective Drugs Act
Actions Overview (1)
|03/07/2018||Introduced in Senate|
03/07/2018 Introduced in Senate
All Actions (1)
|03/07/2018||Read twice and referred to the Committee on the Judiciary.|
Action By: Senate
03/07/2018 Read twice and referred to the Committee on the Judiciary.
|Sen. McCaskill, Claire [D-MO]*||03/07/2018|
|Sen. Perdue, David [R-GA]*||03/07/2018|
|Sen. Ernst, Joni [R-IA]*||03/07/2018|
|Sen. Toomey, Pat [R-PA]*||03/07/2018|
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Judiciary||03/07/2018||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (1)
Introduced in Senate (03/07/2018)
Preserving Access to Cost Effective Drugs Act or the PACED Act
This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.
Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.